Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

0.49USD
8:00pm GMT
Change (% chg)

$0.01 (+1.97%)
Prev Close
$0.48
Open
$0.48
Day's High
$0.50
Day's Low
$0.48
Volume
425,098
Avg. Vol
193,742
52-wk High
$2.04
52-wk Low
$0.18

Chart for

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

  ADXS.OQ Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -2.29 -- --
ROI: -105.74 8.89 13.82
ROE: -116.33 10.00 15.25

Earnings vs. Estimates